Literature DB >> 16527921

Role of the JAK/STAT signaling pathway in diabetic nephropathy.

Mario B Marrero1, Amy K Banes-Berceli, David M Stern, Douglas C Eaton.   

Abstract

Excessive cellular growth is a major contributor to pathological changes associated with diabetic nephropathy. In particular, high glucose-induced growth of glomerular mesangial cells is a characteristic feature of diabetes-induced renal complications. Glomerular mesangial cells respond to traditional growth factors, although in diabetes this occurs in the context of an environment enriched in both circulating vasoactive mediators and high glucose. For example, the vasoactive peptide ANG II has been implicated in the pathogenesis of diabetic renal disease, and recent findings suggest that high glucose and ANG II activate intracellular signaling processes, including the polyol pathway and generation of reactive oxygen species. These pathways activate the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling cascades in glomerular mesangial cells. Activation of the JAK/STAT signaling cascade can stimulate excessive proliferation and growth of glomerular mesangial cells, contributing to diabetic nephropathy. This review focuses on some of the key elements in the diabetic microenvironment, especially high glucose and the accumulation of advanced glycoxidation end products and considers their impact on ANG II and other vasoactive peptide-mediated signaling events in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527921     DOI: 10.1152/ajprenal.00181.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  78 in total

Review 1.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

2.  A novel inhibitor of inducible NOS dimerization protects against cytokine-induced rat beta cell dysfunction.

Authors:  Linlin Zhong; Tuan Tran; Tyler D Baguley; Sang Jun Lee; Adam Henke; Andrew To; Sijia Li; Shan Yu; Fabio A Grieco; Jason Roland; Peter G Schultz; Decio L Eizirik; Nikki Rogers; Arnab K Chartterjee; Matthew S Tremblay; Weijun Shen
Journal:  Br J Pharmacol       Date:  2018-07-14       Impact factor: 8.739

Review 3.  From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.

Authors:  Ying Qian; Eva Feldman; Subramanian Pennathur; Matthias Kretzler; Frank C Brosius
Journal:  Diabetes       Date:  2008-06       Impact factor: 9.461

Review 4.  Inflammation in diabetic kidney disease.

Authors:  Patricia M García-García; María A Getino-Melián; Virginia Domínguez-Pimentel; Juan F Navarro-González
Journal:  World J Diabetes       Date:  2014-08-15

5.  Diabetes-induced renal injury in rats is attenuated by suramin.

Authors:  Midhun C Korrapati; Brooke E Shaner; Benjamin A Neely; Joseph L Alge; John M Arthur; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2012-06-26       Impact factor: 4.030

6.  Reduction of Stat3 activity attenuates HIV-induced kidney injury.

Authors:  Xiaobei Feng; Ting-Chi Lu; Peter Y Chuang; Wei Fang; Krishna Ratnam; Huabao Xiong; Xinshou Ouyang; Yuhong Shen; David E Levy; Deborah Hyink; Mary Klotman; Vivette D'Agati; Ravi Iyengar; Paul E Klotman; John C He
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

7.  Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications.

Authors:  Urmi Sengupta; Sanchaita Ukil; Nevenka Dimitrova; Shipra Agrawal
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

8.  Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy.

Authors:  Ting-Chi Lu; Zhao-Hui Wang; Xiaobei Feng; Peter Y Chuang; Wei Fang; Yuhong Shen; David E Levy; Huabao Xiong; Nan Chen; John Cijiang He
Journal:  Kidney Int       Date:  2009-04-08       Impact factor: 10.612

9.  Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis.

Authors:  Yaojun Liang; Yu Jin; Yuning Li
Journal:  Pediatr Nephrol       Date:  2009-04-07       Impact factor: 3.714

Review 10.  The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease.

Authors:  Futoshi Matsui; Kirstan K Meldrum
Journal:  J Surg Res       Date:  2012-07-17       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.